237 related articles for article (PubMed ID: 17222299)
21. Comparison of topical paromomycin sulfate (twice/day) with intralesional meglumine antimoniate for the treatment of cutaneous leishmaniasis caused by L. major.
Shazad B; Abbaszadeh B; Khamesipour A
Eur J Dermatol; 2005; 15(2):85-7. PubMed ID: 15757817
[TBL] [Abstract][Full Text] [Related]
22. Diffuse cutaneous leishmaniasis in HIV.
Mehta V; Balachandran C; Rao R; Dil SK; Indusri L
Dermatol Online J; 2009 Apr; 15(4):9. PubMed ID: 19450402
[TBL] [Abstract][Full Text] [Related]
23. Treatment of cutaneous leishmaniasis recidivans with a combination of allopurinol and meglumine antimoniate: a clinical and histologic study.
Esfandiarpour I; Dabiri SH
Int J Dermatol; 2007 Aug; 46(8):848-52. PubMed ID: 17651170
[TBL] [Abstract][Full Text] [Related]
24. Rhinophyma-like cutaneous leishmaniasis.
Youssef M; Soua Y; Belhadjali H
Indian J Dermatol Venereol Leprol; 2014; 80(6):537-8. PubMed ID: 25382513
[No Abstract] [Full Text] [Related]
25. Coinfection of
Calvopina M; Aguirre C; Cevallos W; Castillo A; Abbasi I; Warburg A
Am J Trop Med Hyg; 2017 May; 96(5):1151-1154. PubMed ID: 28193741
[TBL] [Abstract][Full Text] [Related]
26. Disseminated mucocutaneous leishmaniasis resulting from chronic use of corticosteroid.
Motta AC; Arruda D; Souza CS; Foss NT
Int J Dermatol; 2003 Sep; 42(9):703-6. PubMed ID: 12956682
[TBL] [Abstract][Full Text] [Related]
27. Slow-growing scaly erythematous plaque on the face and scalp of an elderly woman.
Torres Garcia Y; Escutia Muñoz B; Botella Estrada R
Actas Dermosifiliogr; 2013 Oct; 104(8):715-6. PubMed ID: 24011741
[No Abstract] [Full Text] [Related]
28. Diffuse cutaneous leishmaniasis due to Leishmania major in Senegal.
Develoux M; Diallo S; Dieng Y; Mane I; Huerre M; Pratlong F; Dedet JP; Ndiaye B
Trans R Soc Trop Med Hyg; 1996; 90(4):396-7. PubMed ID: 8882186
[No Abstract] [Full Text] [Related]
29. Leishmaniasis of the lip in a patient with Down's syndrome.
Ferreli C; Atzori L; Zucca M; Pistis P; Aste N
J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):599-602. PubMed ID: 15324405
[TBL] [Abstract][Full Text] [Related]
30. A strange infiltrative plaque on the face.
Guarneri C; Wollina U; Chokoeva A; Lotti TM; Tchernev G
Braz J Infect Dis; 2016; 20(2):214-5. PubMed ID: 26748228
[No Abstract] [Full Text] [Related]
31. Cutaneous and mucocutaneous leishmaniasis resembling borderline-tuberculoid leprosy: a new clinical presentation?
Dassoni F; Abebe Z; Naafs B; Morrone A
Acta Derm Venereol; 2013 Jan; 93(1):74-7. PubMed ID: 22434112
[TBL] [Abstract][Full Text] [Related]
32. Disseminated American cutaneous leishmaniasis.
Bonfante-Garrido R; Barroeta S; de Alejos MA; Meléndez E; Torrealba J; Valdivia O; Momen H; Grimaldi Júnior G
Int J Dermatol; 1996 Aug; 35(8):561-5. PubMed ID: 8854152
[TBL] [Abstract][Full Text] [Related]
33. [Leishmaniasis caused by Leishmania viannia braziliensis (Lvb). A case of atypical course].
Costa JM; Vale KC; França F; Lago EL; Magalhães AV; Marsden PD; Sampaio RN
Rev Soc Bras Med Trop; 1988; 21(2):71-3. PubMed ID: 2854901
[No Abstract] [Full Text] [Related]
34. Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran.
Mohebali M; Fotouhi A; Hooshmand B; Zarei Z; Akhoundi B; Rahnema A; Razaghian AR; Kabir MJ; Nadim A
Acta Trop; 2007 Jul; 103(1):33-40. PubMed ID: 17586452
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of meglumine antimoniate effects on liver, kidney and pancreas function tests in patients with cutaneous leishmaniasis.
Kashani MN; Firooz A; Eskandari SE; Ghoorchi MH; Khamesipour A; Khatami A; Javadi A; Dowlati Y
Eur J Dermatol; 2007; 17(6):513-5. PubMed ID: 17951131
[TBL] [Abstract][Full Text] [Related]
36. [The cutaneous leishmaniasis of the face in Gafsa area, Tunisia].
Masmoudi A; Kitar A; Rebai M; Bouassida S; Turki H; Zahaf A
Bull Soc Pathol Exot; 2005 Dec; 98(5):374-9. PubMed ID: 16425717
[TBL] [Abstract][Full Text] [Related]
37. [A 34-year-old man with lingual tumor. Lingual leishmaniasis in a patient with HIV infection].
Sacristán O; Porcel JM; Panadés MJ; Rubio M
Rev Clin Esp; 2001 Feb; 201(2):103-5. PubMed ID: 11345598
[No Abstract] [Full Text] [Related]
38. Efficacy of cryotherapy versus intralesional meglumine antimoniate (glucantime) for treatment of cutaneous leishmaniasis in children.
Layegh P; Pezeshkpoor F; Soruri AH; Naviafar P; Moghiman T
Am J Trop Med Hyg; 2009 Feb; 80(2):172-5. PubMed ID: 19190206
[TBL] [Abstract][Full Text] [Related]
39. [Postkala-azar dermal leishmaniasis].
de Juan Martín F; Justa Roldán ML; Sáez de Adana Pérez E; Navarro Serrano E; Bouthelier Moreno M; Gilaberte Calzada Y; Fortuño Cebamanos B
An Esp Pediatr; 1997 Jan; 46(1):63-4. PubMed ID: 9082890
[No Abstract] [Full Text] [Related]
40. Successful treatment with miltefosine of disseminated cutaneous leishmaniasis in a severely immunocompromised patient infected with HIV-1.
Schraner C; Hasse B; Hasse U; Baumann D; Faeh A; Burg G; Grimm F; Mathis A; Weber R; Günthard HF
Clin Infect Dis; 2005 Jun; 40(12):e120-4. PubMed ID: 15909255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
